Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare Biotechnology

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > Well capitalized

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Sep 10, 2021 11:38am

19 Views

Post# 33839903

RE:RE:RE:RE:RE:RE:RE:Well capitalized

OK....let's also not forget that this was done with full knowledge and approval by the BoD at that time......and who was part of that board.....hmmmm.....help me out here pumper.....

DavidRosenberg wrote:

DavidRosenberg wrote:

Mil_Man54 wrote: "Due process".....so you're saying it took close to 2yrs of due process before the BoD could act......oh please pumper.....a Borad meeting could have called at anytime....you know by the BoD......they removed Raza so another AD scheme could begin.....I'm guessing that they need FSD funds to pay for the Lucid deal and Raza didn't want to play ball because he didn't benefit enough from it.....so bye bye Raza.....

DavidRosenberg wrote:

Mil_Man54 wrote: Yeah.....I really hope he does a better job than he did in not stopping Raza from tanking the SP.....you know the job the BoD is supposed to do in a timely manner and not 2yrs down the road.....but AD does not have a high bar right now to improve on his past performance....he might have to fill in that hole just to bring the bar to ground level.......wouldn't you agree....pumper.....oh why am I asking.....of course you agree....

DavidRosenberg wrote:

DavidRosenberg wrote:
Only now is anthony management of FSD Pharma the pressure is on him to turn the company around.

FSD Pharma is well-capitalized with a cash of $43.2 million, as of June 30, 2021,

There is DUE PROCESS , you can't kick out a CEO right away , procedural fairness , their mistake for brining RB on the team, now they are fixing it , that shows strength and character
good luck , who knows maybe you will make your money back one day and you can stop complaining on this board

your opinion is valid basher however i disagree , i think RB made a mess of things and paid himself and parkway clinical without explaning why etc whatever was in the information circular from gold proxy that's who i trust

Why no update on how many covid patients tested , cats and dogs after? lol

anyways... FSD 201 has merit if $ELYM trials which are due 1st half of 2022 are positive i think it will reflect on fsd, if trials are negative then vice versa

Dont forget about the improper transaction which can be found here :
Improper Dental Transaction Ed Brennan FSD Pharma